Overall Survival Is Not A Required Primary Endpoint In All Cancer Trials, US FDA Says

 
• By Sue Sutter
  
Gold standard
Overall survival remains the gold standard endpoint, but need not be the primary analysis in every study. • Source: Shutterstock

More from Clinical Trials

More from R&D